Body dysmorphic disorder

Psychiatric Clinics of North America

Volumn 37, Issue 3, 2014, Pages 287-300

  Fang, Angela ^a   Matheny, Natalie L ^a   Wilhelm, Sabine ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Body dysmorphic disorder; Cognitive behavioral therapy; Obsessive compulsive spectrum; Serotonin reuptake inhibitor; Treatment

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

BODY DYSMORPHIC DISORDER; COGNITIVE RESTRUCTURING; COGNITIVE THERAPY; COMPULSIVE PERSONALITY DISORDER; DELUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; ESTHETIC SURGERY; HUMAN; MOTIVATIONAL ENHANCEMENT; NEUROSURGERY; PATHOPHYSIOLOGY; PERCEPTUAL MIRROR RETRAINING; PREVALENCE; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROGNOSIS; PSYCHOEDUCATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; SOCIAL PHOBIA; SUICIDAL BEHAVIOR; TREATMENT DURATION; TREATMENT RESPONSE; BODY DYSMORPHIC DISORDERS; COMORBIDITY; DELUSIONS; MULTIMODALITY CANCER THERAPY; OBSESSIVE-COMPULSIVE DISORDER; PATIENT ATTITUDE; PSYCHOLOGY; SUICIDE;

BODY DYSMORPHIC DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DELUSIONS; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PATIENT ACCEPTANCE OF HEALTH CARE; SEROTONIN UPTAKE INHIBITORS; SUICIDE;

EID: 84906322737     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2014.05.003     Document Type: Review

References (89)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1980, Author, Washington, DC. 3rd edition.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1987, Author, Washington, DC. 3rd edition- revised.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Author, Washington, DC. 4th edition- text revision.
4. Chosak A., Marques L., Greenberg J.L., et al. Body dysmorphic disorder and obsessive-compulsive disorder: similarities, differences and the classification debate. Expert Rev Neurother 2008, 8:1209-1218.
5. Storch E.A., Abramowitz J., Goodman W.K. Where does obsessive-compulsive disorder belong in DSM-V?. Depress Anxiety 2008, 25:336-347.
6. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013, Author, Washington, DC. 5th edition.
7. Phillips K.A. The broken mirror: understanding and treating body dysmorphic disorder (revised and expanded edition) 2005, Oxford University Press, New York.
8. Phillips K.A., Menard W., Fay C., et al. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 2005, 46:317-325.
9. Wilhelm S. Feeling good about the way you look: a program for overcoming body image problems 2006, Guilford Press, New York.
10. Phillips K.A., Diaz S.F. Gender differences in body dysmorphic disorder. JNerv Ment Dis 1997, 185:570-577.
11. Eisen J.L., Phillips K.A., Coles M.E., et al. Insight in obsessive compulsive disorder and body dysmorphic disorder. Compr Psychiatry 2004, 45:10-15.
12. Phillips K.A. Psychosis in body dysmorphic disorder. JPsychiatr Res 2004, 38:63-72.
13. Eisen J.L., Phillips K.A., Baer L., et al. The brown assessment of beliefs scale: reliability and validity. Am J Psychiatry 1998, 155:102-108.
14. Phillips K.A., McElroy S.L., Keck P.E., et al. Acomparison of delusional and nondelusionalbody dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994, 30:179-186.
15. Phillips K.A., Pinto A., Hart A.S., et al. Acomparison of insight in body dysmorphic disorder and obsessive-compulsive disorder. JPsychiatr Res 2012, 46:1293-1299. 10.1016/j.jpsychires.2012.05.016.
16. Phillips K.A. Suicidality in body dysmorphic disorder. Prim psychiatry 2007, 14:58-66.
17. Phillips K.A., Coles M.E., Menard W., et al. Suicidal ideation and suicide attempts in body dysmorphic disorder. JClin Psychiatry 2005, 66:717-725.
18. Phillips K.A., Menard W. Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry 2006, 163:1280-1282.
19. Feusner J.D., Neziroglu F., Wilhelm S., et al. What causes BDD: research findings and a proposed model. Psychiatr Ann 2010, 40:349-355.
20. Atmaca M., Bingol I., Aydin A., et al. Brain morphology of patients with body dysmorphic disorder. JAffect Disord 2010, 123:258-263.
21. Rauch S.L., Phillips K.A., Segal E., et al. Apreliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res Neuroimaging 2003, 122:13-19.
22. Feusner J.D., Townsend J., Bystritsky A., et al. Regional brain volumes and symptom severity in body dysmorphic disorder. Psychiatry Res Neuroimaging 2009, 172:161-167.
23. Feusner J.D., Moody T., Hembacher E., et al. Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. Arch Gen Psychiatry 2010, 67:197-205.
24. Bienvenu O.J., Samuels J.F., Riddle M.A., et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000, 48:287-293.
25. Buhlmann U., Wilhelm S. Cognitive factors in body dysmorphic disorder. Psychiatr Ann 2004, 34:922-926.
26. Neziroglu F., Khemlani-Patel S., Veale D. Social learning theory and cognitive behavioral models of body dysmorphic disorder. Body Image 2008, 5:28-38.
27. Veale D. Advances in a cognitive behavioural model of body dysmorphic disorder. Body Image 2004, 1:113-125.
28. Wilhelm S., Phillips K.A., Steketee G. Cognitive-behavioral therapy for body dysmorphic disorder: a treatment manual 2013, Guilford Press, New York.
29. Veale D., Gournay K., Dryden W., et al. Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav Res Ther 1996, 34:717-729.
30. Buhlmann U., McNally R.J., Wilhelm S., et al. Selective processing of emotional information in body dysmorphic disorder. JAnxiety Disord 2002, 16:289-298.
31. Buhlmann U., Wilhelm S., McNally R.J., et al. Interpretive biases for ambiguous information in body dysmorphic disorder. CNS Spectr 2002, 7:435-436. 441-3.
32. Buhlmann U., Glaesmer H., Mewes R., et al. Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res 2010, 178:171-175.
33. Koran L.M., Abujaoude E., Large M.D., et al. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectrums 2008, 13:316-322.
34. Rief W., Buhlmann U., Wilhelm S., et al. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med 2006, 36:877-885.
35. Bohne A., Wilhelm S., Keuthen N.J., et al. Prevalence of body dysmorphic disorder in a German college student sample. Psychiatry Res 2002, 109:101-104.
36. Bohne A., Keuthen N.J., Wilhelm S., et al. Prevalence of symptoms of body dysmorphic disorder and its correlates: a cross-cultural comparison. Psychosomatics 2002, 43:486-490.
37. Wilhelm S., Otto M.W., Zucker B.G., et al. Prevalence of body dysmorphic disorder in patients with anxiety disorders. JAnxiety Disord 1997, 11:499-502.
38. van der Meer J., van Rood Y.R., van der Wee N.J., et al. Prevalence, demographic and clinical characteristics of body dysmorphic disorder among psychiatric outpatients with mood, anxiety or somatoform disorders. Nord J Psychiatry 2012, 66:232-238.
39. Conroy M., Menard W., Fleming-Ives K., et al. Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting. Gen Hosp Psychiatry 2008, 30:67-72.
40. Grant J.E., Kim S.W., Crow S.J. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. JClin Psychiatry 2001, 62:517-522.
41. Alavi M., Kalafi Y., Dehbozorgi G.R., et al. Body dysmorphic disorder and other psychiatric morbidity in aesthetic rhinoplasty candidates. JPlast Reconstr Aesthet Surg 2011, 64:738-741.
42. Conrado L.A., Hounie A.G., Diniz J.B., et al. Body dysmorphic disorder among dermatologic patients: prevalence and clinical features. JAm Acad Dermatol 2010, 63:235-243.
43. Lai C.S., Lee S.S., Yeh Y.C., et al. Body dysmorphic disorder in patients with cosmetic surgery. Kaohsiung J Med Sci 2010, 26:478-482.
44. Phillips K.A., Menard W., Fay C. Gender similarities and differences in 200 individuals with body dysmorphic disorder. Compr Psychiatry 2006, 47:77-87.
45. Gunstad J., Phillips K.A. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry 2003, 44:270-276.
46. Phillips K.A., Menard W., Quinn E., et al. Afour-year prospective observational follow-up study of course and predictors of course in body dysmorphic disorder. Psychol Med 2013, 43:1109-1117.
47. Phillips K.A., Wilhelm S., Koran L.M., et al. Body dysmorphic disorder: some key issues for DSM-V. Depress Anxiety 2010, 27:573-591.
48. Phillips K.A., McElroy S.L., Hudson J.I., et al. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both?. JClin Psychiatry 1995, 56:41-51.
49. Cororve M.B., Gleaves D.H. Body dysmorphic disorder: a review of conceptualizations, assessment, and treatment strategies. Clin Psychol Rev 2001, 21:949-970.
50. Frare F., Perugi G., Ruffolo G., et al. Obsessive-compulsive disorder and body dysmorphic disorder: a comparison of clinical features. Eur Psychiatry 2004, 19:292-298.
51. Phillips K.A., Pinto A., Menard W., et al. Obsessive-compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders. Depress Anxiety 2007, 24:399-409.
52. Coles M.E., Phillips K.A., Menard W., et al. Body dysmorphic disorder and social phobia: cross-sectional and prospective data. Depress Anxiety 2006, 23:26-33.
53. Fang A., Asnaani A., Gutner C.A., et al. Rejection sensitivity mediates the relationship between social anxiety and bodydysmorphic concerns. JAnxiety Disord 2011, 25:946-949.
54. Kelly M.M., Dalrymple K., Zimmerman M., et al. Acomparison study of body dysmorphic disorder versus social phobia. Psychiatry Res 2013, 205:109-116.
55. Kelly M.M., Walters C., Phillips K.A. Social anxiety and its relationship to functional impairment in body dysmorphic disorder. Behav Ther 2010, 41:143-153.
56. Fang A., Sawyer A.T., Aderka I., et al. Psychological treatment of social anxiety disorder improves body dysmorphic concerns. JAnxiety Disord 2013, 27(7):684-691.
57. Rosen J.C. Body dysmorphic disorder: assessment and treatment. In: body image, eating disorders, and obesity: an integrative guide for assessment and treatment 2001, 149-170. American Psychological Association, Washington, DC.
58. Rosen J.C., Ramirez E. Acomparison of eating disorders and body dysmorphic disorder on body image and psychological adjustment. JPsychosom Res 1998, 44:441-449.
59. Kollei I., Schieber K., de Zwaan M., et al. Body dysmorphic disorder and nonweight-related body image concerns in individuals with eating disorders. Int J Eat Disord 2013, 46:52-59.
60. Phillips K.A., McElroy S.L. Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: theoretical and treatment implications. JNerv Ment Dis 1993, 181:699-702.
61. Phillips K.A., Menard W., Pagano M.E., et al. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. JPsychiatr Res 2006, 40:95-104.
62. Phillips K.A., Kim J.M., Hudson J.I. Body image disturbance in body dysmorphic disorder and eating disorders: obsessions or delusions?. Psychiatr Clin North Am 1995, 18:317-334.
63. Phillips K.A. Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach. CNS Spectrums 2002, 7:453-460. 463.
64. Phillips K.A., Hollander E. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image 2008, 5:13-27.
65. Veale D. Cognitive behavioral therapy for body dysmorphic disorder. Psychiatr Ann 2010, 40:333-340.
66. Phillips K.A., Albertini R.S., Rasmussen S.A. Arandomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry 2002, 59:381-388.
67. Perugi G., Giannotti D., Di Vaio S., et al. Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol 1996, 11:247-254.
68. Phillips K.A., Dwight M.M., McElroy S.L. Efficacy and safety of fluvoxamine in body dysmorphic disorder. JClin Psychiatry 1998, 59:165-171.
69. Phillips K.A., Najjar F. An open-label study of citalopram in body dysmorphic disorder. JClin Psychiatry 2003, 64:715-720.
70. Phillips K.A. An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol 2006, 21:177-179.
71. Hollander E., Allen A., Kwon J., et al. Clomipramine vs. desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 1999, 56:1033-1039.
72. Hollander E., Cohen L., Simeon D., et al. Fluvoxamine treatment of body dysmorphic disorder. JClin Psychopharmacol 1994, 14:75-77.
73. Phillips K.A. Pharmacologic treatment of body dysmorphic disorder. Psychopharmacol Bull 1996, 32:597-605.
74. Phillips K.A., Albertini R.S., Siniscalchi J.M., et al. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. JClin Psychiatry 2001, 62:721-727.
75. Veale D. Cognitive behaviour therapy for body dysmorphic disorder. Disorders of body image 2002, 121-138. Wrightson Biomedical Publishing, Petersfield (England). D.J. Castle, K.A. Phillips (Eds.).
76. Wilhelm S., Phillips K.A., Fama J.M., et al. Modular cognitive behavioral therapy for body dysmorphic disorder. Behav Ther 2011, 42:624-633.
77. Phillips K.A., Hollander E., Rasmussen S.A., et al. Aseverity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull 1997, 33:17-22.
78. Williams J., Hadjistavropoulos T., Sharpe D. Ameta-analysis of psychological and pharmacological treatments for body dysmorphic disorder. Behav Res Ther 2006, 44:99-111.
79. McKay D. Two-year follow-up of behavioral treatment and maintenance for body dysmorphic disorder. Behav Modif 1999, 23:620-629.
80. McKay D., Todaro J., Neziroglu F., et al. Body dysmorphic disorder: a preliminary evaluation of treatment and maintenance using exposure with response prevention. Behav Res Ther 1997, 35:67-70.
81. Rosen J.C., Reiter J., Orosan P. Cognitive-behavioral body image therapy for body dysmorphic disorder. JConsult Clin Psychol 1995, 63:263-269.
82. Wilhelm S., Otto M.W., Lohr B., et al. Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behav Res Ther 1999, 37:71-75.
83. Phillips K.A., Grant J., Siniscalchi J., et al. Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics 2001, 42:504-510.
84. Crerand C.E., Menard M., Phillips K.A. Surgical and minimally invasive cosmetic procedures among persons with body dysmorphic disorder. Ann Plast Surg 2010, 65:11-16.
85. Carroll B.J., Yendrek R., Degroot C., et al. Response of major depression with psychosis and body dysmorphic disorder to ECT. Am J Psychiatry 1994, 151:288-289.
86. Buhlmann U., Winter A. Perceived ugliness: an update on treatment-relevant aspects of body dysmorphic disorder. Curr Psychiatry Rep 2011, 13:283-288.
87. Buhlmann U. Treatment barriers for individuals with body dysmorphic disorder: an Internet survey. JNerv Ment Dis 2011, 199:268-271.
88. Marques L., Weingarden H.M., LeBlanc N.J., et al. Treatment utilization and barriers to treatment engagement among people with body dysmorphic symptoms. JPsychosom Res 2011, 70:286-293.
89. Jain S, Grant JE, Menard W, etal. A chart-review study of SRI continuation treatment versus discontinuation in body dysmorphic disorder. Abstracts, National Institute of Mental Health NCDEU 44th Annual Meeting; Phoenix (AZ), June, 2004. p. 231.